4.2 Review

Treatment of Tobacco Dependence in Mental Health and Addictive Disorders

出版社

SAGE PUBLICATIONS INC
DOI: 10.1177/070674370905400604

关键词

tobacco dependence; mental health; addiction; smoking cessation; smoking reduction; pharmacotherapy; cognitive-behavioural treatment; tobacco ban

资金

  1. National Institute on Drug Abuse (NIDA) [K08 DA017145, K02 DA16611, R01 DA13672, R01 DA14039, R01 DA15757]
  2. National Alliance for Research on Schizophrenia and Depression
  3. Canadian Institutes of Health Research-Canadian Tobacco Control Research Initiative [19588]
  4. Canada Foundation for Innovation
  5. Social Sciences and Humanities Research Council
  6. GlaxoSmithKline [2006]
  7. Pfizer
  8. Sepracor
  9. Targacept
  10. Sanofi-aventis

向作者/读者索取更多资源

People with mental health and addictive (MHA) disorders smoke at high rates and require tobacco treatment as a part of their comprehensive psychiatric care. Psychiatric care providers often do not address tobacco use among people with mental illness, possibly owing to the belief that their patients will not be able to quit successfully or that even short-term abstinence will adversely influence psychiatric status. Progress in the development of treatments has been slow in part because smokers with current MHA disorders have been excluded from most smoking cessation trials. There are several smoking cessation treatment options, including psychological and pharmacological interventions, that should be offered to people with an MHA disorder who smoke. Building motivation and readiness to quit smoking is a major challenge, and therefore motivational interventions are essential. We review the treatment options for people with tobacco dependence and MHA disorders, offer recommendations on tobacco assessment and tailored treatment strategies, and provide suggestions for future research. Treatment efficacy could be enhanced through promoting smoking reduction as an initial treatment goal, extending duration of treatment, and delivering it within an integrated care model that also aims to reduce the availability of tobacco in MHA treatment settings and in the community.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据